-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 10, 2021, " Cell Research " magazine published online a collaborative research paper "Tumor-conditional IL-15 pro-cytokine reactivates" by researcher Peng Hua from the Institute of Biophysics of the Chinese Academy of Sciences and Professor Fu Yangxin from the University of Texas Southwestern Medical Center.
At present, most tumor immunotherapies mainly focus on blocking immunosuppressive signals or activating immunostimulatory signals
Pro-IL-15 reduces systemic toxicity by blocking the activation and expansion of peripheral NK cells and T cells, but still retains effective anti-tumor ability
Dr.
Article link: https://
(Contribution: Peng Hua Research Group)